Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 369 results:
Συντάκτης Τίτλος [ Τύπος![(Asc)](https://www.med.auth.gr/sites/all/modules/biblio/misc/arrow-asc.png)
Φίλτρα: Συντάκτης is Polyzos, Stergios A [Clear All Filters]
Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-γ agonists..
Metabolism. 66, 64-68.
(2017). Non-alcoholic fatty liver disease treatment in patients with type 2 diabetes mellitus; new kids on the block..
Curr Vasc Pharmacol.
(2019). Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines..
Curr Mol Med. 9(3), 299-314.
(2009). Nonalcoholic fatty liver disease test: an external validation cohort..
Hormones (Athens).
(2023). Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease..
J Clin Gastroenterol. 46(4), 272-84.
(2012). Nonalcoholic fatty liver disease: lifestyle and quality of life..
Hormones (Athens).
(2021). Nonalcoholic fatty liver disease: Is it time for combination treatment and a diabetes-like approach?.
Hepatology. 68(1), 389.
(2018).
(2019). Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis..
Hormones (Athens). 13(4), 519-31.
(2014). Nonalcoholic fatty liver disease in males with low testosterone concentrations..
Diabetes Metab Syndr. 14(5), 1571-1577.
(2020). Nonalcoholic fatty liver disease and polycystic ovary syndrome..
Ann Hepatol. 14(6), 941-3.
(2015). Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications..
Diabetes Obes Metab. 24(9), 1702-1720.
(2022). Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy..
Semin Cancer Biol. 93, 20-35.
(2023). Nonalcoholic fatty liver disease and Helicobacter pylori infection. Is it time to address this potential relationship?.
Curr Vasc Pharmacol.
(2023). Nonalcoholic fatty future disease..
Metabolism. 65(8), 1007-16.
(2016). Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment..
Hormones (Athens). 17(4), 573-579.
(2018). No effect of rosuvastatin in the zoledronate-induced acute-phase response..
Calcif Tissue Int. 88(5), 402-8.
(2011). No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial..
Clin Endocrinol (Oxf). 70(4), 522-6.
(2009). Neuroprotection in glaucoma: is there a future role of Helicobacter pylori eradication?.
Exp Eye Res. 92(5), 436-8.
(2011). Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease..
Metabolism. 63(2), 161-7.
(2014). National consensus on infection: the next-day challenge..
Ann Gastroenterol. 33(3), 324-325.
(2020).
(2020). Multiple Vertebral Fractures Following Denosumab Discontinuation: Are We Exaggerating?.
Calcif Tissue Int. 103(1), 107-108.
(2018). Multiple Bidirectionality Brain-Gut Interactions in Patients With Inflammatory Bowel Disease..
Gastroenterology. 155(5), 1651-1652.
(2018).
(2019).